Article Information
History
- March 14, 2023.
Article Versions
- You are currently viewing Version 1 of this article (March 14, 2023 - 06:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hilde T. Juvodden1,*,
- Dag Alnæs2,3,
- Ingrid Agartz4,5,6,
- Ole A. Andreassen2,6,
- Andres Server7,
- Per M. Thorsby8,9,
- Lars T. Westlye2,6,10 and
- Stine Knudsen-Heier1,9
- 1Norwegian Centre of Expertise for Neurodevelopmental Disorders and Hypersomnias (NevSom), Department of Rare Disorders, Oslo University Hospital, Ullevål, Norway
- 2NORMENT Centre, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Norway
- 3Kristiania University College, Oslo, Norway
- 4Norwegian Centre for Mental Disorders Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 5Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
- 6K.G. Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Norway
- 7Department of Radiology and Nuclear medicine, Oslo University Hospital, Oslo, Norway
- 8Hormone Laboratory, Department of Medical Biochemistry, Biochemical Endocrinology and Metabolism Research Group, Oslo University Hospital, Aker, Norway
- 9Department of clinical medicine, University of Oslo, Norway
- 10Department of Psychology, University of Oslo, Norway
- ↵*Correspondence to: Hilde T. Juvodden, Oslo University Hospital, Ullevål Hospital, Norwegian Centre of Expertise for Neurodevelopmental Disorders and Hypersomnias (NevSom), PO Box 4956 Nydalen, NO-0424 OSLO, Norway. Telephone number: +47 916 11 528. Email: hilde.juvodden{at}gmail.com